Lulizumab, CAS 2235419-62-0

Product Description: Lulizumab (Humanized Anti-CD28 Recombinant Antibody) is a selective CD28 blockade, Lulizumab prevents T cell activation by selectively targeting CD28 signaling[1].

Applications: COVID-19-immunoregulation

Formula: N/A

References: [1]Fernandes JC. Therapeutic application of antibody fragments in autoimmune diseases: current state and prospects. Drug Discov Today. 2018 Dec;23(12):1996-2002.

CAS Number: 2235419-62-0

Molecular Weight: N/A

Compound Purity: 95.0

Research Area: Inflammation/Immunology

Solubility: H2O

Target: CD28

• Artikelnummer: MEXHY-P99302-1
• Hersteller: MedChemExpress
• Hersteller Artikelnummer: HY-P99302-1
• Green Labware: Nein
• Verpackungseinheit: 1 mg
• Mengeneinheit: STK